- Joined
- Oct 9, 2007
- Messages
- 47,300 (7.53/day)
- Location
- Hyderabad, India
| System Name | RBMK-1000 |
|---|---|
| Processor | AMD Ryzen 7 5700G |
| Motherboard | ASUS ROG Strix B450-E Gaming |
| Cooling | DeepCool Gammax L240 V2 |
| Memory | 2x 8GB G.Skill Sniper X |
| Video Card(s) | Palit GeForce RTX 2080 SUPER GameRock |
| Storage | Western Digital Black NVMe 512GB |
| Display(s) | BenQ 1440p 60 Hz 27-inch |
| Case | Corsair Carbide 100R |
| Audio Device(s) | ASUS SupremeFX S1220A |
| Power Supply | Cooler Master MWE Gold 650W |
| Mouse | ASUS ROG Strix Impact |
| Keyboard | Gamdias Hermes E2 |
| Software | Windows 11 Pro |
ASUS today announced that the latest ASUS MH series clinical displays have been listed as Class 1 Devices by the US Food and Drug Administration (FDA). These models include the 32-inch 8-megapixel MH3281A, the 27-inch 4-megapixel MH2741A, and the 23.8-inch MH2441A. All three displays are designed for radiology, as well as Picture Archiving and Communication System (PACS) use.
All three monitors meet the DICOM Part 14 Grayscale Standard Display Function (GSDF) AAPM TG270 standard, and each includes a scheduled calibration feature, dynamic brightness compensation, and dynamic DICOM compensation to ensure consistent and highly accurate medical images. The monitors feature an anti-glare, low-reflection (AGLR) coating on the panel, and have undergone stringent performance tests. They have been certified by TÜV Rheinland to ensure flicker-free performance and low blue light emissions. These clinical displays also meet ISO 13485 requirements, and are certified for use in clinics and large medical institutions.
In addition to FDA certification, ASUS is seeking CE marks indicating compliance with EU Medical Device Regulation guidelines as well as approval from the Taiwan Food and Drug Administration (TFDA) for its clinical displays. Aiming to provide a range of new solutions for European and Asia markets, ASUS is also actively pursuing partnerships with major medical institutions across the globe, seeking to better understand industry needs and to respond to ever-changing medical-device market.
View at TechPowerUp Main Site
All three monitors meet the DICOM Part 14 Grayscale Standard Display Function (GSDF) AAPM TG270 standard, and each includes a scheduled calibration feature, dynamic brightness compensation, and dynamic DICOM compensation to ensure consistent and highly accurate medical images. The monitors feature an anti-glare, low-reflection (AGLR) coating on the panel, and have undergone stringent performance tests. They have been certified by TÜV Rheinland to ensure flicker-free performance and low blue light emissions. These clinical displays also meet ISO 13485 requirements, and are certified for use in clinics and large medical institutions.
In addition to FDA certification, ASUS is seeking CE marks indicating compliance with EU Medical Device Regulation guidelines as well as approval from the Taiwan Food and Drug Administration (TFDA) for its clinical displays. Aiming to provide a range of new solutions for European and Asia markets, ASUS is also actively pursuing partnerships with major medical institutions across the globe, seeking to better understand industry needs and to respond to ever-changing medical-device market.
View at TechPowerUp Main Site
At least not until something like this lands in my lap out of eWaste or w/e. Then, I'll pedantically research wth the certs mean...